环境和生活方式因素对炎症性肠病发展的新兴影响
Emerging Impact of Environmental and Lifestyle Factors on the Development of Inflammatory Bowel Disease
DOI: 10.12677/acm.2026.161143, PDF,   
作者: 石杰文, 朱代华*:重庆医科大学附属第二医院胃肠肛肠外科,重庆
关键词: 炎症性肠病环境因素生活方式Inflammatory Bowel Disease Environmental Factors Lifestyle
摘要: 炎症性肠病(IBD),包括克罗恩病和溃疡性结肠炎,是一种由遗传、环境、免疫和微生物因素复杂相互作用引发的慢性胃肠道疾病。近年来,其全球发病率持续上升,尤其是在新兴工业化国家,这凸显了非遗传因素在疾病发生发展中的关键作用。本综述旨在系统阐述环境与生活方式因素对IBD发展的影响,核心内容包括:探讨饮食模式、抗生素使用、空气污染等环境暴露如何通过破坏肠道菌群稳态、损害肠道屏障功能及激活异常免疫反应,从而驱动IBD的发病进程;同时,分析了吸烟、体力活动、睡眠模式及物质使用等生活方式因素对疾病活动与患者预后的调节作用。通过梳理这些因素的作用机制与相互关联,为制定科学的预防策略和综合管理方案提供理论依据。
Abstract: Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic gastrointestinal disorder triggered by complex interactions among genetic, environmental, immune, and microbial factors. In recent years, the global incidence of IBD has been steadily increasing, particularly in emerging industrialized countries, highlighting the critical role of non-genetic factors in the onset and progression of the disease. This review aims to systematically discuss the impact of environmental and lifestyle factors on the development of IBD. Key topics include: exploring how environmental exposures such as dietary patterns, antibiotic use, and air pollution drive the pathogenesis of IBD by disrupting gut microbiota homeostasis, damaging the intestinal barrier function, and activating abnormal immune responses; in addition, the review examines the regulatory effects of lifestyle factors such as smoking, physical activity, sleep patterns, and substance use on disease activity and patient prognosis. By outlining the mechanisms and interconnections of these factors, this review provides a theoretical basis for developing scientific prevention strategies and comprehensive management plans.
文章引用:石杰文, 朱代华. 环境和生活方式因素对炎症性肠病发展的新兴影响[J]. 临床医学进展, 2026, 16(1): 1098-1105. https://doi.org/10.12677/acm.2026.161143

参考文献

[1] Wan, J., Zhou, J., Wang, Z., Liu, D., Zhang, H., Xie, S., et al. (2025) Epidemiology, Pathogenesis, Diagnosis, and Treatment of Inflammatory Bowel Disease: Insights from the Past Two Years. Chinese Medical Journal, 138, 763-776. [Google Scholar] [CrossRef
[2] Calvez, V., Puca, P., Di Vincenzo, F., Del Gaudio, A., Bartocci, B., Murgiano, M., et al. (2025) Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases. Biomedicines, 13, Article 305. [Google Scholar] [CrossRef] [PubMed]
[3] Caparrós, E., Wiest, R., Scharl, M., Rogler, G., Gutiérrez Casbas, A., Yilmaz, B., et al. (2021) Dysbiotic Microbiota Interactions in Crohn’s Disease. Gut Microbes, 13, Article 1949096. [Google Scholar] [CrossRef] [PubMed]
[4] Liang, Y., Li, Y., Lee, C., Yu, Z., Chen, C. and Liang, C. (2024) Ulcerative Colitis: Molecular Insights and Intervention Therapy. Molecular Biomedicine, 5, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[5] Hijos-Mallada, G., Sostres, C. and Gomollón, F. (2022) AINE, toxicidad gastrointestinal y enfermedad inflamatoria intestinal. Gastroenterología y Hepatología, 45, 215-222. [Google Scholar] [CrossRef] [PubMed]
[6] Du, L. and Ha, C. (2020) Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterology Clinics of North America, 49, 643-654. [Google Scholar] [CrossRef] [PubMed]
[7] Campmans-Kuijpers, M.J.E. and Dijkstra, G. (2021) Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (Graid). Nutrients, 13, Article 1067. [Google Scholar] [CrossRef] [PubMed]
[8] Sun, Y., Yuan, S., Chen, X., Sun, J., Kalla, R., Yu, L., et al. (2023) The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort Study. American Journal of Gastroenterology, 118, 511-522. [Google Scholar] [CrossRef] [PubMed]
[9] Qiu, P., Ishimoto, T., Fu, L., Zhang, J., Zhang, Z. and Liu, Y. (2022) The Gut Microbiota in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 733992. [Google Scholar] [CrossRef] [PubMed]
[10] Shan, Y., Lee, M. and Chang, E.B. (2022) The Gut Microbiome and Inflammatory Bowel Diseases. Annual Review of Medicine, 73, 455-468. [Google Scholar] [CrossRef] [PubMed]
[11] Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H. and Gonzalez-Granado, J.M. (2023) Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. International Journal of Molecular Sciences, 24, Article 1526. [Google Scholar] [CrossRef] [PubMed]
[12] Cătană, C., Neagoe, I.B., Cozma, V., Magdaş, C., Tăbăran, F. and Dumitraşcu, D.L. (2015) Contribution of the IL-17/IL-23 Axis to the Pathogenesis of Inflammatory Bowel Disease. World Journal of Gastroenterology, 21, 5823-5830. [Google Scholar] [CrossRef] [PubMed]
[13] Shen, Q., Huang, Z., Yao, J. and Jin, Y. (2022) Extracellular Vesicles-Mediated Interaction within Intestinal Microenvironment in Inflammatory Bowel Disease. Journal of Advanced Research, 37, 221-233. [Google Scholar] [CrossRef] [PubMed]
[14] Roy, S. and Dhaneshwar, S. (2023) Role of Prebiotics, Probiotics, and Synbiotics in Management of Inflammatory Bowel Disease: Current Perspectives. World Journal of Gastroenterology, 29, 2078-2100. [Google Scholar] [CrossRef] [PubMed]
[15] Suarez, R.G., Osornio-Vargas, A.R. and Wine, E. (2022) Ambient Air Pollution and Pediatric Inflammatory Bowel Diseases: An Updated Scoping Review. Digestive Diseases and Sciences, 67, 4342-4354. [Google Scholar] [CrossRef] [PubMed]
[16] Estevinho, M.M., Midya, V., Cohen-Mekelburg, S., Allin, K.H., Fumery, M., Pinho, S.S., et al. (2024) Emerging Role of Environmental Pollutants in Inflammatory Bowel Disease Risk, Outcomes and Underlying Mechanisms. Gut, 74, 477-486. [Google Scholar] [CrossRef] [PubMed]
[17] Carney, H., Marrie, R.A., Bolton, J.M., Patten, S.B., Graff, L.A., Bernstein, C.N., et al. (2020) Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 27, 58-64. [Google Scholar] [CrossRef] [PubMed]
[18] Tavakoli, P., Vollmer-Conna, U., Hadzi-Pavlovic, D. and Grimm, M.C. (2021) A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public Health Reviews, 42, Article 1603990. [Google Scholar] [CrossRef] [PubMed]
[19] Mareschal, J., Douissard, J. and Genton, L. (2022) Physical Activity in Inflammatory Bowel Disease: Benefits, Challenges and Perspectives. Current Opinion in Clinical Nutrition & Metabolic Care, 25, 159-166. [Google Scholar] [CrossRef
[20] Scheffers, L.E., Vos, I.K., Utens, E.M.W.J., Dieleman, G.C., Walet, S., Escher, J.C., et al. (2023) Physical Training and Healthy Diet Improved Bowel Symptoms, Quality of Life, and Fatigue in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition, 77, 214-221. [Google Scholar] [CrossRef
[21] Ma, Y., Yu, S., Li, Q., Zhang, H., Zeng, R., Luo, R., et al. (2024) Sleep Patterns, Genetic Susceptibility, and Digestive Diseases: A Large-Scale Longitudinal Cohort Study. International Journal of Surgery, 110, 5471-5482. [Google Scholar] [CrossRef
[22] Lee, M. and Chang, E.B. (2021) Inflammatory Bowel Diseases (IBD) and the Microbiome—Searching the Crime Scene for Clues. Gastroenterology, 160, 524-537. [Google Scholar] [CrossRef] [PubMed]
[23] Rohmann, N., Geese, T., Nestel, S., Schlicht, K., Geisler, C., Türk, K., et al. (2024) Metabolic and Lifestyle Factors Accelerate Disease Onset and Alter Gut Microbiome in Inflammatory Non-Communicable Diseases. BMC Medicine, 22, Article No. 493. [Google Scholar] [CrossRef] [PubMed]
[24] Niu, Y., Heddes, M., Altaha, B., Birkner, M., Kleigrewe, K., Meng, C., et al. (2024) Targeting the Intestinal Circadian Clock by Meal Timing Ameliorates Gastrointestinal Inflammation. Cellular & Molecular Immunology, 21, 842-855. [Google Scholar] [CrossRef] [PubMed]
[25] Cai, J., Sun, L. and Gonzalez, F.J. (2022) Gut Microbiota-Derived Bile Acids in Intestinal Immunity, Inflammation, and Tumorigenesis. Cell Host & Microbe, 30, 289-300. [Google Scholar] [CrossRef] [PubMed]
[26] Agrawal, M. and Jess, T. (2022) Implications of the Changing Epidemiology of Inflammatory Bowel Disease in a Changing World. United European Gastroenterology Journal, 10, 1113-1120. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, D., Saikam, V., Skrada, K.A., Merlin, D. and Iyer, S.S. (2022) Inflammatory Bowel Disease Biomarkers. Medicinal Research Reviews, 42, 1856-1887. [Google Scholar] [CrossRef] [PubMed]
[28] Parigi, T.L., D’Amico, F., Abreu, M.T., Dignass, A., Dotan, I., Magro, F., et al. (2023) Difficult-to-Treat Inflammatory Bowel Disease: Results from an International Consensus Meeting. The Lancet Gastroenterology & Hepatology, 8, 853-859. [Google Scholar] [CrossRef
[29] Macaluso, F.S., Caprioli, F., Benedan, L., Bezzio, C., Caporali, R., Cauli, A., et al. (2024) The Management of Patients with Inflammatory Bowel Disease-Associated Spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) Recommendations Based on a Pseudo-Delphi Consensus. Autoimmunity Reviews, 23, Article 103533. [Google Scholar] [CrossRef] [PubMed]
[30] Rubin, D.T., Sninsky, C., Siegmund, B., Sans, M., Hart, A., Bressler, B., et al. (2021) International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities between Patients and Physicians from the IBD GAPPS Survey. Inflammatory Bowel Diseases, 27, 1942-1953. [Google Scholar] [CrossRef] [PubMed]